DaRT radiation device for skin and mouth or superficial tumors
Part of Cancer, Infections, Mouth & dental, Skin clinical trials.
This trial tests a targeted radiation device (DaRT seeds) to treat certain cancers on the skin, in the mouth, or in superficial soft tissue. It may help when standard treatment (like surgery or regular radiation/chemo) hasn’t worked, isn’t safe, or isn’t wanted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed cancer in the skin, mouth (oral lining), or superficial soft tissue, checked by biopsy within 6 months
- Your tumor is 7 centimeters or smaller at its widest point
- Your tumor area can be fully covered by the DaRT seeds, including a safety margin around it
- A team of cancer doctors agrees DaRT is an appropriate option for you
- You can have key blood tests and health checks: age 18+, ECOG under 2, and platelets/white cells/liver/kidney and clotting tests meet limits
- You’re not pregnant or breastfeeding, and you can use reliable birth control if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a radiation-emitting device (DaRT) to treat certain cancers on the skin, in the mouth, or in superficial soft tissues. You may qualify if you have a confirmed malignant tumor, enough body strength for treatment, and blood tests and pregnancy status that meet safety limits.
This trial tests whether a targeted internal radiation treatment (DaRT) combined with pembrolizumab (an immune therapy) can shrink recurrent or metastatic head and neck squamous cell cancer that cannot be fully removed with surgery. It may help by making cancer more visible to the immune system while delivering localized radiation to a tumor area.
This trial tests a radiation-emitting device placed near the tumor to treat certain malignant skin cancers that can be fully covered. It may help shrink or control the cancer at the skin site where the device is applied.
This trial tests a special radiation device (DaRT) placed directly into skin cancer tumors. It is designed for patients with weakened immune systems (immunocompromised) who have a single skin cancer lesion on the skin (not spread elsewhere).
This study tests a radiation-emitting device (called DaRT) for treating cancer tumors. It may help shrink or control malignant tumors and researchers will check safety and response to the treatment.
This trial studies DaRT, a treatment given before surgery, to improve outcomes for certain oral cavity squamous cell cancers that can be fully removed. You would be carefully selected using scans and tests to make sure the cancer is in the right place and you can safely receive the treatment.
Hear when a new Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.